MOORFIELD HOUSE SURGERY — All Prescriptions & Medications
Practice Code: B86658 | LEEDS, LS25 1AN
Over the last 12 months, MOORFIELD HOUSE SURGERY prescribed 221,733 items across 619 different medications at a total cost of £1,953,063 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Co-magaldrox (Magnesium/aluminium hydroxide) | 10 | 5,000 | £29 | +23.4% ▲ |
| Sodium citrate (Rectal) | 10 | 208 | £134 | -27.5% ▼ |
| Haloperidol | 10 | 1,454 | £16.0K | -79.0% ▼ |
| Aspirin | 10 | 320 | £10 | +1.8% vs avg |
| Eletriptan | 10 | 60 | £214 | +1.3% vs avg |
| Erythromycin ethylsuccinate | 10 | 1,300 | £134 | -57.2% ▼ |
| Prasterone | 10 | 280 | £152 | +51.5% ▲ |
| Ibandronic acid | 10 | 345 | £329 | -72.5% ▼ |
| Other phosphate supplement preparations | 10 | 400 | £78 | +63.9% ▲ |
| Tizanidine hydrochloride | 10 | 1,096 | £47 | -62.2% ▼ |
| Pilocarpine hydrochloride | 10 | 532 | £249 | -7.0% ▼ |
| 10 | 30 | £327 | -37.5% ▼ | |
| 10 | 166 | £482 | -51.0% ▼ | |
| 10 | 1,190 | £186 | -63.4% ▼ | |
| 10 | 1,200 | £237 | -61.2% ▼ | |
| Mebeverine hydrochloride compound preparations | 11 | 626 | £545 | -2.7% ▼ |
| Fluvastatin sodium | 11 | 77 | £10 | -52.4% ▼ |
| Dornase alfa | 11 | 390 | £6.5K | +59.3% ▲ |
| Ivacaftor | 11 | 77 | £18.3K | +94.1% ▲ |
| Codeine phosphate | 11 | 2,800 | £45 | -23.4% ▼ |
| Acamprosate calcium | 11 | 1,680 | £188 | -68.4% ▼ |
| Exemestane | 11 | 720 | £175 | -66.1% ▼ |
| Powder carbohydrate supplement (0913193) | 11 | 11.0K | £51 | +224.4% ▲ |
| Indometacin | 11 | 683 | £45 | -30.1% ▼ |
| Gentamicin sulfate | 11 | 110 | £209 | +100.2% ▲ |
| Dexpanthenol | 11 | 1,100 | £65 | +110.3% ▲ |
| Pimecrolimus | 11 | 400 | £243 | -35.0% ▼ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 11 | 1,050 | £126 | +26.8% ▲ |
| Lidocaine | 11 | 195 | £185 | -4.3% ▼ |
| 11 | 110 | £128 | -70.4% ▼ | |
| 11 | 48 | £50 | -73.0% ▼ | |
| 11 | 24 | £370 | +7.8% ▲ | |
| 11 | 450 | £836 | -25.9% ▼ | |
| 11 | 1,140 | £836 | -17.2% ▼ | |
| 11 | 330 | £283 | +66.8% ▲ | |
| Sucralfate | 12 | 3,600 | £4.4K | +42.9% ▲ |
| Tinzaparin sodium | 12 | 338 | £3.4K | -19.0% ▼ |
| Aripiprazole | 12 | 12 | £2.6K | -21.2% ▼ |
| Dosulepin hydrochloride | 12 | 1,820 | £393 | -78.8% ▼ |
| Entecavir | 12 | 510 | £5.9K | +58.7% ▲ |
| Alogliptin | 12 | 336 | £303 | -95.3% ▼ |
| Vardenafil | 12 | 120 | £258 | -14.1% ▼ |
| Tablets 71g protein equivalent per 100g (0913205) | 12 | 37.0K | £19.0K | +75.1% ▲ |
| Ketotifen fumarate | 12 | 665 | £153 | +29.0% ▲ |
| Olopatadine | 12 | 60 | £58 | -72.6% ▼ |
| Azelaic acid | 12 | 360 | £77 | -49.8% ▼ |
| 12 | 145 | £325 | -63.4% ▼ | |
| 12 | 12 | £374 | +39.7% ▲ | |
| 12 | 330 | £158 | +49.7% ▲ | |
| 12 | 12 | £585 | +207.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.